Releases
Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
TMF Agent significantly improves quality and consistency while drastically reducing the manual effort in document management. It is built on Medable’s Agent Studio, the industry’s first agentic AI platform for clinical development.
Medable and CVS Health Announce Collaboration to Expand Clinical Trial Access
Medable and CVS Health (NYSE: CVS) today announced a collaboration to expand clinical trial access and engagement for patients at select MinuteClinic™ locations via Medable’s clinical trials software platform. CVS Health Clinical Trial Services™ will manage the relationship.
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform for patient-centered drug development, today announced a strategic partnership to bring clinical trials closer to the patient. The partnership will deliver new decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while improving patient access and experiences to transform biopharmaceutical product development.
Medable Names Veteran SaaS Finance Executive Mike Kourey to Its Board of Directors
PALO ALTO, Calif. — April 7, 2022 — Medable Inc., the leading SaaS platform for patient-centered clinical trials, today announced the appointment of enterprise software veteran and Dialpad CFO Mike Kourey to its board of directors. Kourey, who brings unparalleled expertise in scaling both public and private enterprise software companies, will help guide Medable’s continued rise as a leader in the health technology industry.